ホーム › 尿路上皮（移行上皮）癌 › フロリダ州
フロリダ州における尿路上皮（移行上皮）癌の臨床試験
フロリダ州内の拠点で、尿路上皮（移行上皮）癌に関する22件の研究が参加者を募集しています。
フロリダ州内の都市
公式研究テキスト（英語）
Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
- Mayo Clinic in Florida, Jacksonville
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06265285Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Exelixis Clinical Site #48, Celebration
- Exelixis Clinical Site #11, Gainesville
- Exelixis Clinical Site #78, Jacksonville
- 他2件
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/01更新 · NCT05176483A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
- UF Health Cancer Institute - Gainesville, Gainesville
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06524544Nephroureterectomy With and Without Lymph Node Dissection for Upper Tract Urothelial Cell Carcinoma
- University of Florida Health Science Center, Gainesville
被験者募集中
19歳以上 · 全性別 · 2026/10/01更新 · NCT06262516The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
- Mayo Clinic in Florida, Jacksonville
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07285044Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Holy Cross Hospital, Fort Lauderdale
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT03866382uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
- University of Florida, Gainesville
- Mount Sinai Medical Center of Florida, Inc., Miami
- H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc., Tampa
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/29更新 · NCT05874921A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- BRCR Global-Coral Springs, Coral Springs
- Mayo Clinic Florida, Jacksonville
- Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando
- 他1件
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07277413Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
- MDR Core Network, Boynton Beach
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/24更新 · NCT06047379A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
- AdventHealth Orlando, Orlando
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07218380Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior Immunotherapy
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/21更新 · NCT06439836A Study of Ivonescimab in Combination With Enfortumab Vedotin vs Pembrolizumab in Combination With Enfortumab Vedotin in Metastatic Urothelial Carcinoma
- Research Site, Jacksonville
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/11更新 · NCT07815665Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
- University of Miami, Miami
- Sarah Cannon Research Institute - Lake Nona Florida, Orlando
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/10更新 · NCT06293898Assessment of Decision Tool to Select Women for Gynecologic Sparing Radical Cystectomy
- University of Florida, Gainesville
被験者募集中第2相
18歳〜99歳 · 女性 · 2026/09/09更新 · NCT06184516A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
- Bioresearch Partner - Aventura, Aventura
- University of Florida Health (UF Health), Cancer Center, Gainesville
- Bioresearch Partner - Hialeah Hospital, Hialeah
- 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/03更新 · NCT06774131Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
- Mayo Clinic in Florida, Jacksonville
被験者募集中第1/2相
16歳以上 · 全性別 · 2026/08/20更新 · NCT05269381Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
- Clermont Oncology Center, Clermont
- Mid Florida Hematology and Oncology Center, Orange City
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/29更新 · NCT04198766A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
- Florida Cancer Specialists, Bonita Springs
- Florida Cancer Specialists, Bradenton
- Florida Cancer Specialists, Bradenton
- 他14件
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/22更新 · NCT04879329Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
- Advanced Urology Institute - Daytona Beach, Daytona Beach
被験者募集中
18歳〜88歳 · 全性別 · 2026/07/02更新 · NCT06394869Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer
- Orlando Health, Orlando
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/18更新 · NCT07484022A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
- Dren Investigational Site, Orlando
- Dren Investigational Site, Sarasota
被験者募集中第1相
18歳以上 · 全性別 · 2026/01/07更新 · NCT06999187SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Jacksonville
- Massive Bio SYNERGY-AI site, Miami
- Massive Bio SYNERGY-AI site, Tampa
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。